Asian Journal of Research in Pharmaceutical Sciences

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Design Formulation and Evaluation of Reservoir Type Controlled Released Moxifloxacin Hydrochloride Ocular Insert


Affiliations
1 S. J. Thakkar Pharmacy College, Opp NRI bungalow, Avadh Club Road, Munjka, Kalawad Road, Rajkot, India
2 Matushree V B Manvar Pharmacy College, Dumiyani, Upleta, Rajkot, India
     

   Subscribe/Renew Journal


The present studies were mainly focus to developed ocular controlled release formulation of Moxifloxacin Hydrochloride. Reservoir type of ocular insert was developed by solvent casting method. Total nine formulations was developed using different ratio of Eudragit RS 100 and Eudragit RL100 in combination as a rate controlling membrane and reservoir was prepared by using sodium CMC. All the prepared formulation were subjected for evaluation of physicochemical parameter like thickness, weight variation, percentage moisture absorption, percentage moisture loss, surface pH, sterility, drug content and anti-microbial activity. Evaluated results were shown that all the prepared formulation was suitable for patient compliance. In-vitro release study was carried out by using commercial semipermeable membrane with the help of modified standard cylindrical tube method and best formulation F7 found 98.21 % at the end of 24 hrs. Formulated ocular inserts also passed the test for sterility. The above in vitro release studies revealed that the best ocular inserts formulation followed near to zero-order release kinetics. Higuchi’s plot and Peppa’s plot revealed that the mechanism of drug release involved in all the formulations was super case II transport diffusion. The antimicrobial study was shown that formulation was able to inhibit the microbial growth for extended period of time. The controlled release ocular insert was more suitable as compared to conventional dosage form.

Keywords

Reservoir Drug Delivery System, Ocular Insert, Moxifloxacin Hydrochloride, Eudragit RS100, Eudragit RL 100.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Sreenivas SA, Hiremath SP, Godbole AM. Ofloxacin ocular inserts: Design, Formulation and Evaluation. Iranian Journal of Pharmacology & Therapeutics. 5(1); 2006:159-162.

  • Khan S, Ali A, Singhavi D, Yeole P. Controlled Ocular Delivery of Acyclovir through Rate Controlling Ocular Insert of Eudragit: A Technical Note. AAPS Pharm Sci Tech. 9(1); 2008: 1-3.

  • Rathore KS, Nema RK, Review on Ocular Inserts. International Journal of Pharm Tech Research.1(2): 2009:164-169.

  • Kaur IP, Kanwar M. Ocular preparations: the formulation approach. Development and Industrial Pharmacy. 28(5);2002: 473-493.

  • http://www.rxlist.com/quixin-drug.htm

  • http://www.drugs.com/cdi/Moxifloxacin Hydrochloride-eyedrops. html

  • Karthikeyan D, Bhowmick M, Pandey VP, Sengottuvelu S, Sonkar S. Design and Evaluation of Ofloxacin Extended Release Ocular Inserts For Once a Day Therapy. Research Journal of Pharmacy and Technology. 1(4);2008: 460-468.

  • Dhanaraju MD, Sivakumar VR, Subhashree R, Bhaskar K. Bioadhesive ocusert matrix from ophthalmic administration of ciprofloxacin hydrochloride. Journal of Pharmacy Reserach. 39(4); 2002: 222-224.

  • Mishra DN, Gilhotra RM, Design and characterization of bioadhesive in situ gelling ocular inserts of gaifloxacin sesquihydrate. DARU. 16(1);2008: 1-8.

  • Khanna R., Agrawal SP and Alka Ahuja “Preparation and Evaluation of Mucoadhesive buccal films of Clotrimazole for oral candida infections”. Indian Journal of Pharmaceutical Science. 59(6);1997: 299-305.

  • Manvi FV. Formulation of a transdermal Drug Delivery System of Ketotifen Fumarate. Indian Journal of Pharmaceutical Science. 65(3); 2003: 239-43.

  • Patel UL, Chotai NP, Nagda CD, Patel MP, Patel KN. Formulation and in vitro evaluation of moxifloxacin hydrochloride ophthalmic inserts. International Journal of Pharmaceutical Research. 1(1); 2009: 23-30.

  • Pharmacopoeia of India. (1996). 4th edition, vol. I. Controller of publication, Ministry of Health and Family Welfare, Government of India, New Delhi. 190.

  • Saettone MF, Giaccinni B, Ravecca S, La Marca F, Tota G. Polymers effect on ocular bioavailability- the influence of different liquid vehicles on mydratic response of tropicamide in humans and in rabbits. International Journal of Pharmaceutics. 20(1); 1984: 187–202.

  • Charoo NA, Kohli K, Ali A, Anwer A. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulation: in vitro and in vivo studies. Drug Development and Industrial Pharmacy. 29(2);2003: 215-221.

  • Abhilash AS, Jayprakash S, Nagarajan M, Design and evaluation of timolo maleate ocuserts. Indian Drugs. 67(3);2005: 311-314.

  • Sultana Y, Mohammad A, Ali A, Ocular inserts for controlled delivery of pefloxacin mesylate:Preparation and evaluation. Acta Pharm. 55; 2005: 305–314.

  • Patel U, Chaudhary KA, Chotai NP, Nagada C, Patel KN. Formulation and Evaluation of Indomethacin Ophthalmic Inserts. Indian Journal of Pharmaceutical Education and Research. 42(4);2008: 348-350.


Abstract Views: 836

PDF Views: 81




  • Design Formulation and Evaluation of Reservoir Type Controlled Released Moxifloxacin Hydrochloride Ocular Insert

Abstract Views: 836  |  PDF Views: 81

Authors

Ramesh B. Parmar
S. J. Thakkar Pharmacy College, Opp NRI bungalow, Avadh Club Road, Munjka, Kalawad Road, Rajkot, India
H. M. Tank
Matushree V B Manvar Pharmacy College, Dumiyani, Upleta, Rajkot, India

Abstract


The present studies were mainly focus to developed ocular controlled release formulation of Moxifloxacin Hydrochloride. Reservoir type of ocular insert was developed by solvent casting method. Total nine formulations was developed using different ratio of Eudragit RS 100 and Eudragit RL100 in combination as a rate controlling membrane and reservoir was prepared by using sodium CMC. All the prepared formulation were subjected for evaluation of physicochemical parameter like thickness, weight variation, percentage moisture absorption, percentage moisture loss, surface pH, sterility, drug content and anti-microbial activity. Evaluated results were shown that all the prepared formulation was suitable for patient compliance. In-vitro release study was carried out by using commercial semipermeable membrane with the help of modified standard cylindrical tube method and best formulation F7 found 98.21 % at the end of 24 hrs. Formulated ocular inserts also passed the test for sterility. The above in vitro release studies revealed that the best ocular inserts formulation followed near to zero-order release kinetics. Higuchi’s plot and Peppa’s plot revealed that the mechanism of drug release involved in all the formulations was super case II transport diffusion. The antimicrobial study was shown that formulation was able to inhibit the microbial growth for extended period of time. The controlled release ocular insert was more suitable as compared to conventional dosage form.

Keywords


Reservoir Drug Delivery System, Ocular Insert, Moxifloxacin Hydrochloride, Eudragit RS100, Eudragit RL 100.

References